News
2h
Live Science on MSNCan weight loss drugs help you drink less alcohol?There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
Consumers are urged to understand which GLP-1 medications are safe, approved, and legal after May 22 If you're one of the ...
2d
MedPage Today on MSNGLP-1 Agonists May Help Prevent Weight Gain for People Trying to Quit SmokingXavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...
2d
FOX61 on MSNConnecticut's Attorney General announces legal action against 'bootleg' GLP-1 weight loss drugs sold onlineThe companies are allegedly selling "research grade" GLP-1 weight loss drugs that are not FDA-approved, and are selling the products without a pharmacy license.
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results